Studies suggest that speech processing areas of the brain play an important role in producing auditory hallucinations (AHs). The PI has reported that delivering 1-Hertz repetitive transcranial magnetic stimulation (rTMS) to the left temporoparietal cortex - a brain region underlying speech perception - produces statistically significant improvements in AHs relative to sham simulation. In a follow-up study, the PI used individualized fMRI maps of abnormal speech processing neurocircuitry to position rTMS in multiple cortical sites, and has found that targeting Wernicke's region and a homologous right-sided region in the superior temporal gyrus (STG) optimized clinical improvement of AHs. The proposed study will enroll 90 patients with a diagnosis of schizophrenia and medication-resistant AHs in a more extended, double- masked rTMS trial. Stimulation will be positioned using structural MRI over the left Wernicke's site and right-sided STG site previously found to have optimized clinical response.
Specific Aim #1 is to demonstrate that MRI-positioned 1-Hz rTMS, delivered to the Wernicke's and right STG sites, each for 5 sessions in randomized order, results in greater clinical improvement in AHs compared to sham stimulation.
Specific Aim #2 is to determine if alterations in cerebral laterality predict optimal hemisphere of stimulation in reducing AHs, and the degree of improvement elicited by rTMS at each of the two sites.
Specific Aim #3 is to demonstrate that a third 5-session series of active rTMS directed to the left/right site found to optimize clinical improvement in the first 10 sessions produces greater improvements in AHs compared to sham stimulation positioned according to the same algorithm.
Specific Aim #4 is to demonstrate prospectively that a higher level of hallucination frequency at baseline is a statistical moderator of 1-Hz rTMS in reducing AHs. This study will provide critical information regarding positioning strategies that optimize rTMS for AHs, as well as new insights regarding underlying pathophysiology. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
1R01MH073673-01A1
Application #
7030666
Study Section
Special Emphasis Panel (ZMH1-ERB-D (06))
Program Officer
Hillefors, MI
Project Start
2006-02-01
Project End
2011-01-31
Budget Start
2006-02-01
Budget End
2007-01-31
Support Year
1
Fiscal Year
2006
Total Cost
$468,819
Indirect Cost
Name
Yale University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Ford, Judith M; Morris, Sarah E; Hoffman, Ralph E et al. (2014) Studying hallucinations within the NIMH RDoC framework. Schizophr Bull 40 Suppl 4:S295-304
Hoffman, Ralph E; Wu, Kun; Pittman, Brian et al. (2013) Transcranial magnetic stimulation of Wernicke's and Right homologous sites to curtail ""voices"": a randomized trial. Biol Psychiatry 73:1008-14
Allen, Paul; Modinos, Gemma; Hubl, Daniela et al. (2012) Neuroimaging auditory hallucinations in schizophrenia: from neuroanatomy to neurochemistry and beyond. Schizophr Bull 38:695-703
Hoffman, Ralph E; Pittman, Brian; Constable, R Todd et al. (2011) Time course of regional brain activity accompanying auditory verbal hallucinations in schizophrenia. Br J Psychiatry 198:277-83
Hoffman, Ralph E; Fernandez, Thomas; Pittman, Brian et al. (2011) Elevated functional connectivity along a corticostriatal loop and the mechanism of auditory/verbal hallucinations in patients with schizophrenia. Biol Psychiatry 69:407-14
Hoffman, Ralph E; Hampson, Michelle (2011) Functional connectivity studies of patients with auditory verbal hallucinations. Front Hum Neurosci 6:6
Hoffman, Ralph E (2010) Revisiting Arieti's ""listening attitude"" and hallucinated voices. Schizophr Bull 36:440-2
Kennedy, J Phillip; Bridges, Thomas M; Gentry, Patrick R et al. (2009) Synthesis and structure-activity relationships of allosteric potentiators of the m(4) muscarinic acetylcholine receptor. ChemMedChem 4:1600-7
Bridges, Thomas M; Marlo, Joy E; Niswender, Colleen M et al. (2009) Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins. J Med Chem 52:3445-8
Hoffman, Ralph E (2007) A social deafferentation hypothesis for induction of active schizophrenia. Schizophr Bull 33:1066-70